Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 1230424
[patent_doc_number] => 06692746
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-02-17
[patent_title] => 'Tumor killing effects of enterotoxins, superantigens, and related compounds'
[patent_app_type] => B1
[patent_app_number] => 09/708008
[patent_app_country] => US
[patent_app_date] => 2000-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23152
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/692/06692746.pdf
[firstpage_image] =>[orig_patent_app_number] => 09708008
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/708008 | Tumor killing effects of enterotoxins, superantigens, and related compounds | Nov 7, 2000 | Issued |
Array
(
[id] => 3790917
[patent_doc_number] => 05780298
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-14
[patent_title] => 'DNA encoding the sn-RNP-A antigen and fragments thereof'
[patent_app_type] => 1
[patent_app_number] => 8/959096
[patent_app_country] => US
[patent_app_date] => 1997-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 7
[patent_no_of_words] => 1991
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/780/05780298.pdf
[firstpage_image] =>[orig_patent_app_number] => 959096
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/959096 | DNA encoding the sn-RNP-A antigen and fragments thereof | Oct 22, 1997 | Issued |
Array
(
[id] => 4022801
[patent_doc_number] => 05882898
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-16
[patent_title] => 'Streptococcus pneumoniae polynucleotides which encode folyl-polyglutamate synthetase (FPGS) polypeptides'
[patent_app_type] => 1
[patent_app_number] => 8/934846
[patent_app_country] => US
[patent_app_date] => 1997-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11677
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/882/05882898.pdf
[firstpage_image] =>[orig_patent_app_number] => 934846
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/934846 | Streptococcus pneumoniae polynucleotides which encode folyl-polyglutamate synthetase (FPGS) polypeptides | Sep 21, 1997 | Issued |
Array
(
[id] => 4022769
[patent_doc_number] => 05882896
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-16
[patent_title] => 'M protein'
[patent_app_type] => 1
[patent_app_number] => 8/929418
[patent_app_country] => US
[patent_app_date] => 1997-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11241
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/882/05882896.pdf
[firstpage_image] =>[orig_patent_app_number] => 929418
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/929418 | M protein | Sep 14, 1997 | Issued |
Array
(
[id] => 3963882
[patent_doc_number] => 05885805
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-23
[patent_title] => 'gbpA'
[patent_app_type] => 1
[patent_app_number] => 8/915107
[patent_app_country] => US
[patent_app_date] => 1997-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14095
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/885/05885805.pdf
[firstpage_image] =>[orig_patent_app_number] => 915107
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/915107 | gbpA | Aug 19, 1997 | Issued |
Array
(
[id] => 3920891
[patent_doc_number] => 05876722
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-02
[patent_title] => 'DNA encoding Derf II, the major mite allergen, host cells containing such DNA and methods for producing Derf II'
[patent_app_type] => 1
[patent_app_number] => 8/910075
[patent_app_country] => US
[patent_app_date] => 1997-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3801
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/876/05876722.pdf
[firstpage_image] =>[orig_patent_app_number] => 910075
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/910075 | DNA encoding Derf II, the major mite allergen, host cells containing such DNA and methods for producing Derf II | Aug 11, 1997 | Issued |
08/879529 | A NOVEL STREPTOCOCCAL TWO COMPONENT SIGNAL TRANSDUCTION SYSTEM HISTIDIN KINASE | Jun 19, 1997 | Abandoned |
Array
(
[id] => 3871134
[patent_doc_number] => 05837825
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-17
[patent_title] => 'Campylobacter jejuni flagellin/Escherichia coli LT-B fusion protein'
[patent_app_type] => 1
[patent_app_number] => 8/829026
[patent_app_country] => US
[patent_app_date] => 1997-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7142
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/837/05837825.pdf
[firstpage_image] =>[orig_patent_app_number] => 829026
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/829026 | Campylobacter jejuni flagellin/Escherichia coli LT-B fusion protein | Mar 30, 1997 | Issued |
08/971997 | COMPOSITION FOR THE INHIBITION OF BONE RESORPTION COMPRISING INTERLEUKIN-6 RECEPTOR ANTIBODY | Feb 20, 1997 | Abandoned |
Array
(
[id] => 3838276
[patent_doc_number] => 05744353
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-28
[patent_title] => 'Cytolytic T cell lines which bind to complexes of tumor rejection antigens and HLA-B44 molecules'
[patent_app_type] => 1
[patent_app_number] => 8/796883
[patent_app_country] => US
[patent_app_date] => 1997-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 29
[patent_no_of_words] => 13838
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/744/05744353.pdf
[firstpage_image] =>[orig_patent_app_number] => 796883
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/796883 | Cytolytic T cell lines which bind to complexes of tumor rejection antigens and HLA-B44 molecules | Feb 5, 1997 | Issued |
Array
(
[id] => 4005837
[patent_doc_number] => 05888810
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-30
[patent_title] => 'Campylobacteri jejuni flagellin-escherichia coli LT-B fusion protein'
[patent_app_type] => 1
[patent_app_number] => 8/784218
[patent_app_country] => US
[patent_app_date] => 1997-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7140
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/888/05888810.pdf
[firstpage_image] =>[orig_patent_app_number] => 784218
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/784218 | Campylobacteri jejuni flagellin-escherichia coli LT-B fusion protein | Jan 15, 1997 | Issued |
Array
(
[id] => 3781517
[patent_doc_number] => 05736141
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-07
[patent_title] => 'Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and Freund\'s adjuvant'
[patent_app_type] => 1
[patent_app_number] => 8/739812
[patent_app_country] => US
[patent_app_date] => 1996-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4665
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/736/05736141.pdf
[firstpage_image] =>[orig_patent_app_number] => 739812
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/739812 | Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and Freund's adjuvant | Oct 29, 1996 | Issued |
Array
(
[id] => 4355607
[patent_doc_number] => 06291639
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-18
[patent_title] => 'Metal-binding cystein-free peptides for diagnostic and therapeutical purposes, methods for their production, and pharmaceuticals containing these compounds'
[patent_app_type] => 1
[patent_app_number] => 8/635928
[patent_app_country] => US
[patent_app_date] => 1996-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 3
[patent_no_of_words] => 12532
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 390
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/291/06291639.pdf
[firstpage_image] =>[orig_patent_app_number] => 635928
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/635928 | Metal-binding cystein-free peptides for diagnostic and therapeutical purposes, methods for their production, and pharmaceuticals containing these compounds | Sep 19, 1996 | Issued |
Array
(
[id] => 3811094
[patent_doc_number] => 05770208
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-23
[patent_title] => 'Staphylococcus aureus B-linked hexosamine antigen'
[patent_app_type] => 1
[patent_app_number] => 8/712438
[patent_app_country] => US
[patent_app_date] => 1996-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5205
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/770/05770208.pdf
[firstpage_image] =>[orig_patent_app_number] => 712438
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/712438 | Staphylococcus aureus B-linked hexosamine antigen | Sep 10, 1996 | Issued |
Array
(
[id] => 3879717
[patent_doc_number] => 05747653
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-05
[patent_title] => 'Method of producing of an antimeningococcic hyperimmune gamma globulin and gamma globulin produced by method'
[patent_app_type] => 1
[patent_app_number] => 8/692055
[patent_app_country] => US
[patent_app_date] => 1996-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6343
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 320
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/747/05747653.pdf
[firstpage_image] =>[orig_patent_app_number] => 692055
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/692055 | Method of producing of an antimeningococcic hyperimmune gamma globulin and gamma globulin produced by method | Aug 1, 1996 | Issued |
Array
(
[id] => 3949526
[patent_doc_number] => 05955432
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-21
[patent_title] => 'Metabolic effects of certain glutathione analogs'
[patent_app_type] => 1
[patent_app_number] => 8/675095
[patent_app_country] => US
[patent_app_date] => 1996-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 33
[patent_no_of_words] => 10372
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/955/05955432.pdf
[firstpage_image] =>[orig_patent_app_number] => 675095
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/675095 | Metabolic effects of certain glutathione analogs | Jul 2, 1996 | Issued |
Array
(
[id] => 4040969
[patent_doc_number] => 05874251
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-23
[patent_title] => 'DNA encoding the Taenia crassiceps ten kilodalton antigen'
[patent_app_type] => 1
[patent_app_number] => 8/648496
[patent_app_country] => US
[patent_app_date] => 1996-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7751
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/874/05874251.pdf
[firstpage_image] =>[orig_patent_app_number] => 648496
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/648496 | DNA encoding the Taenia crassiceps ten kilodalton antigen | May 14, 1996 | Issued |
08/586635 | PREPARATIONS OF STABILIZED IMMUNOGLOBULINS AND PROCESS FOR THEIR PREPARATION | Mar 28, 1996 | Abandoned |
Array
(
[id] => 3824932
[patent_doc_number] => 05783422
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-21
[patent_title] => 'DNA fragment coding for squamous cell carcinoma-associated antigen'
[patent_app_type] => 1
[patent_app_number] => 8/568147
[patent_app_country] => US
[patent_app_date] => 1995-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7599
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/783/05783422.pdf
[firstpage_image] =>[orig_patent_app_number] => 568147
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/568147 | DNA fragment coding for squamous cell carcinoma-associated antigen | Dec 5, 1995 | Issued |
08/561685 | DNA ENCODING THE SNRNP-A ANTIGEN AND FRAGMENTS THEREOF | Nov 21, 1995 | Abandoned |